SCHEMBL9507075

SCHEMBL9507075

C#CNCCCCNC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24245454 0.82
SCHEMBL27383471 0.78
SCHEMBL27609361 0.76
SCHEMBL9499226 0.76 EPHX1 (0.48)
SCHEMBL9349578 0.76 EPHX1 (0.48)
SCHEMBL28180308 0.76 EPHX1 (0.48)
SCHEMBL27600186 0.76 EPHX1 (0.48)
SCHEMBL331659 0.74
SCHEMBL484336 0.74
SCHEMBL977724 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2509949-B1 PYRIDINONE HYDROXYCYCLOPENTYL CARBOXAMIDES: HIV INTEGRASE INHIBITORS WITH THERAPEUTIC APPLICATIONS UNIV GEORGIA (US) 2014-04-23 EP claimed
EP-0248217-B1 USE OF ORNITHINE DECARBOXYLASE INHIBITOR FOR PREPARING A MEDICAMENT FOR USE IN THE TREATMENT, IN CONJUCTION WITH LAK CELLS AND INTERLEUKIN-2, OF TUMORS MERRELL DOW PHARMACEUTICALS INC. (US) 1993-07-28 EP claimed
EP-0288055-B1 USE OF ODC INHIBITORS, DACARBAZINE, AND INTERFERON, IN THE TREATMENT OF MALIGNANT MELANOMA MERRELL DOW PHARMACEUTICALS INC. (US) 1992-07-15 EP claimed